The diagnostic performance of GPC-3 observed in our cohort (AUC = 0.711) broadly aligns with data from an earlier meta-analysis, which reported an AUC of 0.82, based on 12 studies evaluating GPC-3 in serum for HCC diagnosis [26]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.